| Product Name | MF | CAS | Details |
|---|
| Sofalcone | C27H30O6 | 64506-49-6 | Details |
| H-AMDSNTLEL-OH | Details |
| Phe-Leu-OH | C15H22N2O3 | 3303-55-7 | Details |
| Bz-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH2 | C49H61N9O8 | 141636-65-9 | Details |
| Viniferol D | C42H32O9 | 625096-18-6 | Details |
| 2-(3-Fluoro-4-methoxyphenyl)propanoic acid | C10H11FO3 | 79281-00-8 | Details |
| 6-Bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-amine | C11H14BrN | 165730-13-2 | Details |
| 1-Methyl-1H-pyrrole-2-carbonitrile | C6H6N2 | 34884-10-1 | Details |
| S-Benzylthioacetimidate, hydrochloride | C9H11NSHCl | 32894-07-8 | Details |
| Methyl 5-[(2-formyl-6-methoxyphenoxy)methyl]furan-2-carboxylate | C15H14O6 | 438219-58-0 | Details |
| 1-(4-chloro-3-nitrobenzenesulfonyl)piperidine-4-carboxylic acid | C12H13ClN2O6S | 368427-83-2 | Details |
| Cytostatin sodium | C21H34NaO7P | 457070-06-3 | Details |
| 9-Mesityl-1,3,6,8-tetramethoxy-10-phenylacridin-10-ium tetrafluoroborate | C32H32BF4NO4 | 1965330-61-3 | Details |
| tert-Butyl 6-oxo-2-azaspiro[4.4]nonane-2-carboxylate | C13H21NO3 | 1319716-43-2 | Details |
| 2-Methyl-2-(trifluoromethyl)morpholine hydrochloride | C6H11ClF3NO | 1848952-59-9 | Details |
| 4-Methyl-3-quinolinamine | C10H10N2 | 50878-90-5 | Details |
| N-(7-Oxadecyl)deoxynojirimycin | C15H31NO5 | 160632-05-3 | Details |
| PHYHIP Blocking Peptide | Details |
| GGPS1 Blocking Peptide | Details |
| 2-(3-Bromo-4-chlorophenyl)acetic acid | C8H6BrClO2 | 90004-80-1 | Details |
| 1-(Prop-2-enoyl)-1,2,3,4-tetrahydroquinoline-6-carboxylic acid | C13H13NO3 | 1094284-48-6 | Details |
| 1-Methyl-2'-O-methylinosine | C12H16N4O5 | 65150-69-8 | Details |
| 1-{[1,2,4]Triazolo[4,3-a]pyrazin-8-yl}piperidine | C10H13N5 | 1878022-44-6 | Details |
| rac-(1R,4S,5S)-4-Phenyl-2-oxabicyclo[2.1.1]hexane-5-carboxylic acid | C12H12O3 | 2759497-30-6 | Details |
| (1R,2R)-Boc-aminocyclopentane carboxylic acid | C11H19NO4 | 245115-25-7 | Details |
| 4-(6-Chloro-pyridazin-3-yloxy)-piperidine-1-carboxylic acid tert-butyl ester | C14H20ClN3O3 | 442199-16-8 | Details |
| 2-(4-Chlorophenyl)propane-1,3-diol | C9H11ClO2 | 122098-61-7 | Details |
| 1-(Methoxymethyl)-4-methyl-1H-pyrazole-5-carbaldehyde | C7H10N2O2 | 1803581-64-7 | Details |
| HO-PEG15-OH | C30H62O16 | 28821-35-4 | Details |
| 3-[Diethoxy(methyl)silyl]propyl methacrylate | C12H24O4Si | 65100-04-1 | Details |
| 1,2,3-Tri-O-acetyl-b-D-ribofuranuronic acid methyl ester | C12H16O9 | 68673-84-7 | Details |
| 1-(1,3-Benzothiazol-6-yl)ethan-1-amine | C9H10N2S | 916201-65-5 | Details |
| Parathyroid Hormone (Human, 1-44) | C225H366N68O61S2 | 85568-24-7 | Details |
| Benz[A]anthracene-7-methanol | C19H14O | 16110-13-7 | Details |
| MAP2B antibody | Details |
| 2-Hydroxy-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one | C11H13NO2 | 73251-26-0 | Details |
| 4-Hydroxypyridine | C5H5NO | 626-64-2 | Details |
| Resazurin, sodium salt, Certified by Biological Stain Commission | C12H8NNaO4 | 62758-13-8 | Details |
| 4-Hydroxybenzaldehyde | C7H6O2 | 123-08-0 | Details |
| DOTA-tris(TBE)-Amido-dPEG?11-Maleimide | Details |
| 1-(Thiophen-2-ylmethyl)-1H-1,2,3-triazole-4-carboxylic acid | C8H7N3O2S | 1284940-06-2 | Details |
| EGR2 antibody | Details |
| 2-Chloro-5-ethynylpyridine | C7H4ClN | 263012-63-1 | Details |
| Periplocoside F | C63H104O23 | 119902-17-9 | Details |
| H-KTSAVLQ-OH | Details |
| Preisocalamendiol | C15H24O | 25645-19-6 | Details |
| CMK | C18H19ClN4O2 | 821794-90-5 | Details |
| 2-[(4-Aminopyridin-2-yl)oxy]ethan-1-ol | C7H10N2O2 | 1251131-77-7 | Details |
| YTHDF1 antibody | Details |
| Sodium 5-methylpyridazine-3-carboxylate | C6H7N2NaO2 | 1955557-83-1 | Details |
| MMP Biotinylated Substrate I | C53H84N14O11S | Details |
| Ethyl 3-(1-methyl-1H-pyrazol-4-yl)butanoate | C10H16N2O2 | 1909347-90-5 | Details |
| N-(Oxolan-3-yl)azetidin-3-amine dihydrochloride | 2137851-79-5 | Details |
| Tylotoin | Details |
| DL-alpha-Methylpalmitic acid methyl ester | C18H36O2 | 2490-53-1 | Details |
| 3-Methyl-5-nitro-1-phenyl-1H-pyrazolo[3,4-b]pyridine | C13H10N4O2 | 98157-52-9 | Details |
| 2-[3-(Trifluoromethyl)phenoxymethyl]oxirane | C10H9F3O2 | 585-45-5 | Details |
| 5′-Nucleotidase human | 9027-73-0 | Details |
| J14 | C28H25ClN4O2S | 1043854-13-2 | Details |
| RNF144B antibody | Details |
| (4R)-6-(Propan-2-yl)-3,4-dihydro-2H-1-benzopyran-4-ol | C12H16O2 | 1567968-24-4 | Details |
| 4-Amino-N-(butan-2-yl)-3-methylbenzamide | C12H18N2O | 926233-21-8 | Details |
| Methyl 4-(2-acetamidopropyl)benzoate | C13H17NO3 | 1542490-88-9 | Details |
| N-{[4-(Chloromethyl)phenyl]methyl}acetamide | C10H12ClNO | 223512-41-2 | Details |
| Arganine B | C63H102O33 | 144425-21-8 | Details |
| {[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]methyl}amine hydrochloride | C4H5ClF3N3O | 1364677-67-7 | Details |
| DCUN1D3 Blocking Peptide | Details |
| 3-Amino-4-(methoxymethyl)oxan-4-ol | 2171579-41-0 | Details |
| 5-Methoxy-4,7-dimethyl-2,3-dihydro-1H-indol-2-one | C11H13NO2 | 327615-31-6 | Details |
| H-Arg-Val-OH acetate salt | C11H23N5O3 | 2896-20-0 | Details |
| Murabutide | C23H40N4O11 | 74817-61-1 | Details |
| 2-Chloro-6-[(3-methoxyphenyl)methoxy]benzaldehyde | C15H13ClO3 | 1021241-46-2 | Details |
| (3R,4R)-rel-3,4-Piperidinediol Hydrochloride | C5H12ClNO2 | 443648-97-3 | Details |
| H-GLIQLVEGV-OH | Details |
| 4'-O-Methyl-3,9-dihydropunctatin | C18H18O6 | 27245-80-3 | Details |
| 3',4',5'-Trimethoxyflavanone | Details |
| 3-Methoxy-4-(propan-2-yloxy)benzonitrile | C11H13NO2 | 757192-64-6 | Details |
| 2-(4-Methoxyphenoxy)ethane-1-thiol | C9H12O2S | 649739-49-1 | Details |
| 2-(1H-Imidazol-2-yl)acetic acid hydrochloride | C5H7ClN2O2 | 1297344-60-5 | Details |
| 1-(Furan-2-yl)ethane-1-thiol | C6H8OS | 96631-04-8 | Details |
| 2-(4-(Trifluoromethyl)phenyl)cyclopropanecarboxamide | C11H10F3NO | 1374509-68-8 | Details |
| [5-Cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl]acetic acid | C9H10F2N2O2 | 1002032-66-7 | Details |
| 1-(4-Hydroxyphenyl)-3-(propan-2-yl)-2,3-dihydro-1H-imidazol-2-one | C12H14N2O2 | 1784003-53-7 | Details |
| (1-Phenyl-ethyl)-pyridin-4-ylmethyl-amine | C14H16N2 | 289476-22-8 | Details |
| 1-(Carboxymethyl)pyrrolidine-2-carboxylic acid | C7H11NO4 | 5626-40-4 | Details |
| N-[4-(Aminosulfonyl)phenyl]-2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxamide | C22H22N4O4S2 | 1572646-93-5 | Details |
| 3-(3-Amino-5-methyl-1H-pyrazol-1-yl)propanoic acid hydrochloride | C7H11N3O2 | 1431963-44-8 | Details |
| 1-(2-Methylbenzoyl)piperidin-4-one | C13H15NO2 | 203186-44-1 | Details |
| 2-(3,4-Dimethoxyphenyl)-1,3-thiazole-4-carboxylicacid | C12H11NO4S | 132307-22-3 | Details |
| 2-(2-Chloro-6-methylpyridin-3-yl)acetic acid | C8H8ClNO2 | 1000567-19-0 | Details |
| JC-171 | C16H17ClN2O5S | 2112809-98-8 | Details |
| 5-Bromo-2-(pyridin-4-yl)pyrimidine | C9H6BrN3 | 1240594-22-2 | Details |
| Mating Factor aSK2 | C81H106N18O19S | 89718-47-8 | Details |
| 2-[5-(4-Fluorophenyl)-1,2-oxazol-3-yl]acetic acid | C11H8FNO3 | 1018584-37-6 | Details |
| 4-(Fluorosulfonyl)-2-methylbenzoic acid | C8H7FO4S | 1934400-55-1 | Details |
| 2-(2,6-Difluorophenyl)-2-(dimethylamino)acetic acid hydrochloride | C10H12ClF2NO2 | 1423024-51-4 | Details |
| H-YISPWILAV-OH | Details |
| Hexokinase 2 protein (His tag) | Details |
| PER3 antibody | Details |
| H-DPGSAAPYLK^-OH | Details |
| Product Total： Product Page： | ||||
| 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 | ||||